Literature DB >> 29735693

Deubiquitinating enzyme USP3 controls CHK1 chromatin association and activation.

Yu-Che Cheng1, Sheau-Yann Shieh2.   

Abstract

Checkpoint kinase 1 (CHK1), a Ser/Thr protein kinase, is modified by the K63-linked ubiquitin chain in response to genotoxic stress, which promotes its nuclear localization, chromatin association, and activation. Interestingly, this bulky modification is linked to a critical residue, K132, at the kinase active site. It is unclear how this modification affects the kinase activity and how it is removed to enable the release of CHK1 from chromatin. Herein, we show that the K63-linked ubiquitin chain at CHK1's K132 residue has an inhibitory effect on the kinase activity. Furthermore, we demonstrate that this modification can be removed by ubiquitin-specific protease 3 (USP3), a deubiquitinating enzyme that targets K63-linked ubiquitin chains. Wild-type USP3, but not the catalytically defective or nuclear localization sequence-deficient mutants, reduced CHK1 K63-linked ubiquitination. Conversely, USP3 knockdown elevated K63-linked ubiquitination of the kinase, leading to prolonged CHK1 chromatin association and phosphorylation. Paradoxically, by removing the bulky ubiquitin chain at the active site, USP3 also increased the accessibility of CHK1 to its substrates. Thus, our findings on the dual roles of USP3 (namely, one to release CHK1 from the chromatin and the other to open up the active site) provide further insights into the regulation of CHK1 following DNA damage.

Entities:  

Keywords:  CHK1; DNA damage response; USP3; deubiquitination; genome stability

Mesh:

Substances:

Year:  2018        PMID: 29735693      PMCID: PMC6003459          DOI: 10.1073/pnas.1719856115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Chk1 and p21 cooperate to prevent apoptosis during DNA replication fork stress.

Authors:  Rene Rodriguez; Mark Meuth
Journal:  Mol Biol Cell       Date:  2005-11-09       Impact factor: 4.138

2.  USP3 counteracts RNF168 via deubiquitinating H2A and γH2AX at lysine 13 and 15.

Authors:  Nidhi Sharma; Qianzheng Zhu; Gulzar Wani; Jingshan He; Qi-en Wang; Altaf A Wani
Journal:  Cell Cycle       Date:  2013-10-24       Impact factor: 4.534

3.  Fine-tuning of DNA damage-dependent ubiquitination by OTUB2 supports the DNA repair pathway choice.

Authors:  Kiyoko Kato; Kazuhiro Nakajima; Ayako Ui; Yuri Muto-Terao; Hideaki Ogiwara; Shinichiro Nakada
Journal:  Mol Cell       Date:  2014-02-20       Impact factor: 17.970

4.  Human USP3 is a chromatin modifier required for S phase progression and genome stability.

Authors:  Francesco Nicassio; Nadia Corrado; Joseph H A Vissers; Liliana B Areces; Steven Bergink; Jurgen A Marteijn; Bart Geverts; Adriaan B Houtsmuller; Wim Vermeulen; Pier Paolo Di Fiore; Elisabetta Citterio
Journal:  Curr Biol       Date:  2007-11-01       Impact factor: 10.834

5.  Candidate tumor suppressor BTG3 maintains genomic stability by promoting Lys63-linked ubiquitination and activation of the checkpoint kinase CHK1.

Authors:  Yu-Che Cheng; Tsong-Yu Lin; Sheau-Yann Shieh
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-26       Impact factor: 11.205

6.  The E3 ligase TRAF6 regulates Akt ubiquitination and activation.

Authors:  Wei-Lei Yang; Jing Wang; Chia-Hsin Chan; Szu-Wei Lee; Alejandro D Campos; Betty Lamothe; Lana Hur; Brian C Grabiner; Xin Lin; Bryant G Darnay; Hui-Kuan Lin
Journal:  Science       Date:  2009-08-28       Impact factor: 47.728

7.  The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1.

Authors:  Yi-Hung Ou; Pei-Han Chung; Fu-Fei Hsu; Te-Ping Sun; Wen-Ying Chang; Sheau-Yann Shieh
Journal:  EMBO J       Date:  2007-08-09       Impact factor: 11.598

8.  DNA damage checkpoint maintenance through sustained Chk1 activity.

Authors:  Christine Latif; Nicole R den Elzen; Matthew J O'Connell
Journal:  J Cell Sci       Date:  2004-06-22       Impact factor: 5.285

9.  CYLD negatively regulates transforming growth factor-β-signalling via deubiquitinating Akt.

Authors:  Jae Hyang Lim; Hirofumi Jono; Kensei Komatsu; Chang-Hoon Woo; Jiyun Lee; Masanori Miyata; Takashi Matsuno; Xiangbin Xu; Yuxian Huang; Wenhong Zhang; Soo Hyun Park; Yu-Il Kim; Yoo-Duk Choi; Huahao Shen; Kyung-Sun Heo; Haodong Xu; Patricia Bourne; Tomoaki Koga; Haidong Xu; Chen Yan; Binghe Wang; Lin-Feng Chen; Xin-Hua Feng; Jian-Dong Li
Journal:  Nat Commun       Date:  2012-04-10       Impact factor: 14.919

10.  Tight regulation of ubiquitin-mediated DNA damage response by USP3 preserves the functional integrity of hematopoietic stem cells.

Authors:  Cesare Lancini; Paul C M van den Berk; Joseph H A Vissers; Gaetano Gargiulo; Ji-Ying Song; Danielle Hulsman; Michela Serresi; Ellen Tanger; Marleen Blom; Conchita Vens; Maarten van Lohuizen; Heinz Jacobs; Elisabetta Citterio
Journal:  J Exp Med       Date:  2014-08-11       Impact factor: 14.307

View more
  9 in total

1.  A Catalytically Independent Function of Human DNA Polymerase Kappa Controls the Stability and Abundance of Checkpoint Kinase 1.

Authors:  Marina Dall'Osto; Laura Pierini; Nicolas Valery; Jean-Sébastien Hoffmann; Marie-Jeanne Pillaire
Journal:  Mol Cell Biol       Date:  2021-08-16       Impact factor: 4.272

2.  Deubiquitinase OTUD6A promotes breast cancer progression by increasing TopBP1 stability and rendering tumor cells resistant to DNA-damaging therapy.

Authors:  Yan Zhao; Xinping Huang; Dan Zhu; Min Wei; Jiechen Luo; Shuyu Yu; Yonglu Tian; Xiaofeng Zheng
Journal:  Cell Death Differ       Date:  2022-06-29       Impact factor: 15.828

3.  Ubiquitin-specific protease 3 facilitates cell proliferation by deubiquitinating pyruvate kinase L/R in gallbladder cancer.

Authors:  Ruo-Peng Liang; Xiao-Xue Zhang; Jie Zhao; Rong-Tao Zhu; Wei-Jie Wang; Qin-Wei Lu; Yu-Ling Sun
Journal:  Lab Invest       Date:  2022-09-30       Impact factor: 5.502

4.  USP3 promotes breast cancer cell proliferation by deubiquitinating KLF5.

Authors:  Yingying Wu; Junying Qin; Fubing Li; Chuanyu Yang; Zhen Li; Zhongmei Zhou; Hailin Zhang; Yunxi Li; Xinye Wang; Rong Liu; Qian Tao; Wenlin Chen; Ceshi Chen
Journal:  J Biol Chem       Date:  2019-10-17       Impact factor: 5.157

5.  Ubiquitin-specific protease 3 promotes cell migration and invasion by interacting with and deubiquitinating SUZ12 in gastric cancer.

Authors:  Xiaosheng Wu; Mengwei Liu; Huiqiong Zhu; Jing Wang; Weiyu Dai; Jiaying Li; Danping Zhu; Weimei Tang; Yizhi Xiao; Jianjiao Lin; Wenjing Zhang; Yong Sun; Yi Zhang; Yaying Chen; Guoxin Li; Aimin Li; Li Xiang; Side Liu; Jide Wang
Journal:  J Exp Clin Cancer Res       Date:  2019-06-24

6.  Basal CHK1 activity safeguards its stability to maintain intrinsic S-phase checkpoint functions.

Authors:  Jone Michelena; Marco Gatti; Federico Teloni; Ralph Imhof; Matthias Altmeyer
Journal:  J Cell Biol       Date:  2019-07-31       Impact factor: 10.539

7.  Ubiquitination of the DNA-damage checkpoint kinase CHK1 by TRAF4 is required for CHK1 activation.

Authors:  Xinfang Yu; Wei Li; Haidan Liu; Qipan Deng; Xu Wang; Hui Hu; Zijun Y Xu-Monette; Wei Xiong; Zhongxin Lu; Ken H Young; Wei Wang; Yong Li
Journal:  J Hematol Oncol       Date:  2020-05-01       Impact factor: 17.388

8.  An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability.

Authors:  Zsuzsanna Nagy; Janith A Seneviratne; Maxwell Kanikevich; William Chang; Chelsea Mayoh; Pooja Venkat; Yanhua Du; Cizhong Jiang; Alice Salib; Jessica Koach; Daniel R Carter; Rituparna Mittra; Tao Liu; Michael W Parker; Belamy B Cheung; Glenn M Marshall
Journal:  Nat Commun       Date:  2021-03-25       Impact factor: 14.919

9.  Chk1 Inhibition Hinders the Restoration of H3.1K56 and H3.3K56 Acetylation and Reprograms Gene Transcription After DNA Damage Repair.

Authors:  Nan Ding; Zhiang Shao; Fangyun Yuan; Pei Qu; Ping Li; Dong Lu; Jufang Wang; Qianzheng Zhu
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.